Objective measurement and clinical significance of IDO1 protein in hormone receptor-positive breast cancer
Gestores bibliográficos
Compartir
item.contributor.advisor
ORCID:
Journal Title
Journal ISSN
Volume Title
Publisher
BioMed Central
item.page.isbn
item.page.issn
item.page.issne
item.page.doiurl
item.page.extent
9
item.page.accessRights
item.page.other
item.page.references
Abstract
BACKGROUND:
Immunostimulatory therapies targeting immune-suppressive pathways produce durable responses in advanced solid tumors. Indoleamine 2,3-dioxygenase (IDO) is the rate-limiting oxidoreductase ...
Description
item.page.coverage.spatial
item.page.sponsorship
Citation
J Immunother Cancer. 2017 Oct 17;5(1):81
item.page.dc.rights
item.page.dc.rights.url
Estadísticas de uso
1 0,8 0,5 0,3 0
Agosto 2025Septiembre 2025Octubre 2025Noviembre 2025Diciembre 2025Enero 2026Febrero 2026